Speaker Profile

Ph.D., Co-founder and Program Director, Life Science Technologies, imec
Biography

Liesbet Lagae oversees the emerging R&D, the public funded activities and early business creation. She holds a PhD degree from the KU Leuven, Belgium for her work on Magnetic Random Access Memories obtained under an IWT grant. As a young group leader, she has initiated the field of molecular and cellular biochips leveraging silicon technologies at IMEC, Belgium. The life science program has grown from emerging activities to a mature business line that provides smart silicon chip solutions to the life science industry. Applications include medical diagnostics, point-of-care solutions, DNA sequencing, cytometry, bioreactors, neuroprobes, implants. She holds a prestigious ERC consolidator grant for developing a platform on single cell analysis and sorting. She has (co-) authored 150 peer-reviewed papers in international journals and holds 15 patents in the field.

Liquid Biopsy Showcase: imec
Imec is the world-leading R&D and innovation hub in nanoelectronics and digital technologies. As a trusted partner for companies, startups and academia we bring together brilliant minds from all over the world in a creative and stimulating environment.

Liquid Biopsies Go Digital
Making liquid biopsies part of standard personalized medicine requires development of next-generation point-of-care devices able to reach clinically meaningful sensitivities, simplify sample preparation, as well as reduce costs and footprint of the instruments. An integrated end-to-end approach, from microfluidic cell capture and sorting of relevant cell populations, to rapid on-chip sample preparation, PCR and data analysis, will enable full exploitation of the potential utility of liquid biopsies in aiding clinical decision and improving patient outcomes.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!